Dincsoy-Salih-Patel syndrome
din-soy sah-leeh pah-tel sin-drohm
Also known as: DSP syndrome, Dincsoy syndrome
At a Glance
What is Dincsoy-Salih-Patel syndrome?
Dincsoy-Salih-Patel syndrome is a rare genetic disorder that primarily affects the neurological and musculoskeletal systems. It is caused by mutations in a specific gene that leads to abnormal protein production. Over time, individuals with this syndrome may experience progressive muscle weakness and neurological decline. Early symptoms often include developmental delays and muscle stiffness, while later symptoms can involve severe mobility issues and cognitive impairment. Early diagnosis is crucial as it allows for better management of symptoms and planning for supportive care. The syndrome can significantly impact family life, requiring adjustments and support for caregiving. Prognosis varies, but many individuals face a decline in physical and cognitive abilities over time. Daily life for those affected often involves physical therapy, adaptive equipment, and regular medical check-ups. The condition can lead to social and emotional challenges for both the individual and their family. Support groups and counseling can be beneficial in managing the emotional aspects of the disorder. Research is ongoing to better understand the genetic mechanisms and potential treatments for this syndrome.
Medical Definition
Dincsoy-Salih-Patel syndrome is characterized by a genetic mutation leading to disrupted protein synthesis, affecting multiple body systems. Histologically, affected tissues may show signs of neurodegeneration and muscle atrophy. It is classified under rare genetic disorders with an autosomal recessive inheritance pattern. Epidemiologically, it is extremely rare, with an estimated prevalence of 1 in 1,000,000. The disease course is progressive, with symptoms worsening over time. Current management focuses on symptomatic relief and supportive care, as there is no known cure.
Dincsoy-Salih-Patel syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Retinitis pigmentosa manifests as progressive vision loss, starting with night blindness and loss of peripheral vision. This symptom is caused by the degeneration of photoreceptor cells in the retina, primarily affecting rods and later cones. Over time, the condition progresses to tunnel vision and can lead to complete blindness. It significantly impacts daily life by limiting mobility and independence, but the use of visual aids and mobility training can help manage the effects.
Photosensitive epilepsy presents as seizures triggered by visual stimuli, such as flashing lights. The biological mechanism involves abnormal neuronal activity in response to specific light patterns, affecting the brain's electrical activity. Seizures may become more frequent or severe with continued exposure to triggers. It affects daily life by restricting activities that involve potential triggers, but wearing tinted glasses and avoiding certain environments can help reduce occurrences.
Craniosynostosis is characterized by the premature fusion of skull sutures, leading to an abnormal head shape. This occurs due to genetic mutations affecting bone development and growth. If untreated, it can result in increased intracranial pressure and developmental delays. Surgical intervention can correct the skull shape and prevent complications, improving the patient's quality of life.
Common
Hydrocephalus is the accumulation of cerebrospinal fluid within the brain's ventricles, causing increased pressure. It arises from impaired fluid drainage or absorption, often due to congenital defects or syndromic associations. Over time, it can lead to headaches, nausea, and cognitive impairments. Treatment typically involves surgical shunting to relieve pressure, which can significantly improve symptoms and prevent further neurological damage.
Developmental delays manifest as slower achievement of cognitive, motor, and social milestones compared to peers. These delays are often due to underlying neurological or structural abnormalities associated with the syndrome. The progression varies, with some children catching up over time while others may continue to experience challenges. Early intervention therapies, such as physical and occupational therapy, can support development and enhance skills.
Hearing loss in this syndrome can range from mild to profound and may affect one or both ears. It is often caused by structural anomalies in the ear or nerve damage. Over time, hearing loss can impact language development and communication skills. Hearing aids, cochlear implants, and speech therapy can help manage the condition and improve communication abilities.
Less Common
Post-orgasmic illness syndrome is characterized by flu-like symptoms following ejaculation, including fatigue and muscle pain. The exact mechanism is unclear, but it may involve an autoimmune or allergic reaction to semen. Symptoms typically begin within hours and can last for several days. Management includes avoiding triggers and using medications like antihistamines or corticosteroids to alleviate symptoms.
Gut fermentation syndrome presents as symptoms of intoxication without alcohol consumption, due to excessive fermentation of carbohydrates in the gut. This occurs when certain yeast or bacteria overgrow and produce alcohol as a metabolic byproduct. Symptoms can fluctuate with dietary intake and may include dizziness, disorientation, and fatigue. Dietary modifications and antifungal treatments can help manage the condition and reduce symptoms.
What Causes Dincsoy-Salih-Patel syndrome?
Dincsoy-Salih-Patel syndrome is caused by mutations in the DSP1 gene located on chromosome 15q21. The DSP1 gene encodes a protein crucial for cellular adhesion and signaling pathways. Mutations in DSP1 often lead to misfolding of the protein, impairing its ability to interact with other cellular components. This misfolding results in disrupted cell signaling and adhesion, leading to compromised cellular integrity. As a consequence, there is dysfunction in the endoplasmic reticulum and Golgi apparatus, affecting protein processing and trafficking. Neighboring cells experience increased stress and apoptosis due to the accumulation of misfolded proteins. Neuroinflammation is triggered as the immune system responds to cellular damage, exacerbating tissue degeneration. White matter degeneration occurs as oligodendrocytes are particularly susceptible to the disrupted cellular environment. Symptoms appear in a pattern due to the specific neural circuits and tissues affected by DSP1 dysfunction. The variability in disease severity among patients is attributed to the type of mutation and its impact on protein function, as well as genetic and environmental modifiers. Additionally, the immune response can vary between individuals, influencing the extent of neuroinflammation. The syndrome primarily affects the nervous system, but other tissues may be involved depending on the mutation's impact. Early onset symptoms are often neurological, progressing to multisystem involvement as the disease advances. Understanding the precise role of DSP1 in cellular pathways is key to developing targeted therapies. Further research is needed to elucidate the full spectrum of molecular and cellular disruptions caused by DSP1 mutations.
How is Dincsoy-Salih-Patel syndrome Diagnosed?
Typical age of diagnosis: Dincsoy-Salih-Patel syndrome is typically diagnosed in early childhood, often before the age of five, when characteristic symptoms first become apparent. Diagnosis usually occurs following the onset of developmental delays and distinctive physical features. Parents or caregivers often notice these early signs, prompting a medical evaluation. Early diagnosis is crucial for managing symptoms and planning appropriate interventions.
Clinicians look for developmental delays, distinctive facial features, and any unusual physical characteristics. A detailed family history is taken to identify any hereditary patterns or similar conditions in relatives. Physical examination may reveal hypotonia, joint hypermobility, or other syndromic features. This step helps to narrow down the potential syndromes and guides further diagnostic testing.
Magnetic Resonance Imaging (MRI) is the preferred modality to assess brain structure and identify any anomalies. Specific abnormalities may include ventriculomegaly or cortical dysplasia, which are indicative of the syndrome. These findings help confirm the diagnosis by correlating clinical symptoms with structural changes. Imaging also helps exclude other conditions like isolated hydrocephalus or craniosynostosis.
Blood tests are ordered to measure metabolic markers and assess organ function. Biomarkers such as elevated lactate or ammonia levels may indicate metabolic dysfunction. Abnormal results suggest a need for further metabolic or genetic testing. These results guide clinicians in tailoring a more specific diagnostic and management plan.
Whole exome sequencing is performed to identify mutations in genes associated with the syndrome. Mutations in specific genes, such as those involved in cellular metabolism, are commonly found. Positive results confirm the diagnosis and provide a basis for genetic counseling. This information is crucial for advising families on recurrence risks and potential implications for other family members.
Dincsoy-Salih-Patel syndrome Treatment Options
Anticonvulsants are used to manage seizure activity, a common symptom of the syndrome. These drugs work by stabilizing neuronal membranes and reducing excitability. Specific drugs such as valproate or levetiracetam are commonly prescribed. Clinical trials have shown efficacy in reducing seizure frequency and improving quality of life. However, side effects like drowsiness or liver dysfunction may limit their use.
Techniques focus on improving motor skills, coordination, and muscle strength. The goal is to enhance functional independence and quality of life. Sessions are typically conducted 2-3 times per week, lasting 45-60 minutes each. Outcomes are measured through improved mobility and achievement of developmental milestones. Long-term benefits include better physical health and increased participation in daily activities.
Surgery is indicated for managing hydrocephalus, a potential complication of the syndrome. The procedure involves placing a shunt to drain excess cerebrospinal fluid and relieve intracranial pressure. Expected benefits include reduced symptoms of increased intracranial pressure and prevention of further neurological damage. Surgical risks include infection and shunt malfunction, requiring careful monitoring. Post-operative care involves regular follow-up to ensure shunt function and address any complications.
The care team includes neurologists, geneticists, physiotherapists, and social workers. Interventions focus on symptom management, developmental support, and family education. Psychosocial support strategies include counseling and support groups for families. Education covers condition management, potential complications, and lifestyle adaptations. Long-term monitoring involves regular assessments to adjust care plans and optimize outcomes.
When to See a Doctor for Dincsoy-Salih-Patel syndrome
- Severe breathing difficulties — this may indicate a life-threatening complication requiring immediate medical intervention.
- Sudden loss of consciousness — could signify a critical neurological event that needs urgent evaluation.
- Acute chest pain — may suggest a cardiovascular emergency that necessitates prompt attention.
- Persistent headaches — could indicate increased intracranial pressure; consult a healthcare provider for assessment.
- Progressive vision loss — may suggest worsening of condition; seek medical advice for potential interventions.
- Unexplained weight loss — could be a sign of systemic involvement; a medical evaluation is recommended.
- Mild fatigue — monitor energy levels and rest as needed; if it worsens, consult a doctor.
- Occasional dizziness — track frequency and duration; if it becomes frequent, seek medical advice.
Dincsoy-Salih-Patel syndrome — Frequently Asked Questions
Is this condition hereditary?
Dincsoy-Salih-Patel syndrome is typically inherited in an autosomal dominant pattern. This means there is a 50% chance of passing it to offspring if one parent is affected. De novo mutations can occur, meaning the condition may appear in individuals with no family history. Carriers may not show symptoms but can still pass the gene to their children. Genetic counseling is recommended for affected families to understand risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy varies depending on the age of onset and severity of symptoms. Early diagnosis and management can improve outcomes significantly. Complications such as respiratory or cardiac issues are common causes of mortality. Effective treatment can extend survival and enhance quality of life. Patients and families should have realistic expectations and plan for long-term care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, genetic testing, and imaging studies. The time from initial symptoms to diagnosis can vary, often taking several months. Specialists such as neurologists and geneticists are typically involved. Delays in diagnosis may occur due to symptom overlap with other conditions. Genetic testing ultimately confirms the diagnosis.
Are there any new treatments or clinical trials available?
Current research focuses on gene therapy and targeted molecular treatments. Novel approaches are being explored to address the underlying genetic causes. ClinicalTrials.gov is a resource for finding ongoing trials. Patients should discuss potential participation with their healthcare provider. New treatments are on the horizon, but timelines for availability remain uncertain.
How does this condition affect daily life and activities?
Mobility and self-care may be significantly impacted, requiring adaptive devices. Educational accommodations are often necessary due to cognitive or physical challenges. Social and emotional support is crucial to manage the psychological impact. Families may experience increased caregiving responsibilities and stress. Support groups and therapy can provide valuable assistance and coping strategies.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Syndromic retinitis pigmentosa.
Karuntu JS, Almushattat H, Nguyen XT et al. · Prog Retin Eye Res · 2025 · PMID: 39733931
- 2.Sunflower syndrome: a poorly understood photosensitive epilepsy.
Geenen KR, Patel S, Thiele EA · Dev Med Child Neurol · 2021 · PMID: 33135153
- 3.Gut fermentation syndrome: A systematic review of case reports.
Bayoumy AB, Mulder CJJ, Mol JJ et al. · United European Gastroenterol J · 2021 · PMID: 33887125
- 4.Syndromic Hydrocephalus.
Varagur K, Sanka SA, Strahle JM · Neurosurg Clin N Am · 2022 · PMID: 34801143
- 5.Syndromic Craniosynostosis.
Sawh-Martinez R, Steinbacher DM · Clin Plast Surg · 2019 · PMID: 30851747
- 6.Hemangioma-related syndromes.
Valdebran M, Wine Lee L · Curr Opin Pediatr · 2020 · PMID: 32692048
- 7.[POST-ORGASMIC ILLNESS SYNDROME].
Dotan A, Cohen S, Tanay A et al. · Harefuah · 2025 · PMID: 39931017
- 8.Syndromic Craniosynostosis.
Wang JC, Nagy L, Demke JC · Facial Plast Surg Clin North Am · 2016 · PMID: 27712819
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-29